Radiotherapy, inflammation, and the myeloid perspective

Medical Review · Published 2026-07-24 · DOI 10.1515/mr-2026-0032

Free full text

Authors (5)

Kaiting Yang, András Piffkó, Chuanhui Han, Liufu Deng, Ralph R. Weichselbaum

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yang, K., Piffkó, A., Han, C., et al. (2026). Radiotherapy, inflammation, and the myeloid perspective. Medical Review. https://doi.org/10.1515/mr-2026-0032

Related articles

• Myeloid-Derived Suppressor Cells and Radiotherapy: Regulation and Clinical Implications · Journal of Cancer · 2026 · Cites or is cited by this article
• When biomarkers for major depressive disorder remain elusive · Medical Review · 2024 · Same journal
• Gaseous biomarkers speak medical conditions · Medical Review · 2026 · Same journal
• Unfolding ecDNA as a pan-cancer therapeutic target · Medical Review · 2025 · Same journal
• The AI doctor will see you soon: from assistants to autonomous practitioners · Medical Review · 2025 · Same journal
• Target discovery-directed pharmacological mechanism elucidation of bioactive natural products · Medical Review · 2025 · Same journal
• Severe trauma care: advances and future directions in diagnostic and therapeutic techniques and information technology support · Medical Review · 2026 · Same journal
• Artificial intelligence-based software as a medical device: regulatory evolution toward continuous oversight · Medical Review · 2026 · Same journal
• Proactive personalized early warning systems: the next frontier in climate–health preparedness · Medical Review · 2026 · Same journal
• Transfer RNA-derived small RNAs (tsRNAs) in Alzheimer’s disease: emerging mechanisms and diagnostic potential · Medical Review · 2026 · Same journal